Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Development ; 143(12): 2238-47, 2016 06 15.
Article in English | MEDLINE | ID: mdl-27151947

ABSTRACT

Mammalian oocytes contain lipid droplets that are a store of fatty acids, whose metabolism plays a substantial role in pre-implantation development. Fluorescent staining has previously been used to image lipid droplets in mammalian oocytes and embryos, but this method is not quantitative and often incompatible with live cell imaging and subsequent development. Here we have applied chemically specific, label-free coherent anti-Stokes Raman scattering (CARS) microscopy to mouse oocytes and pre-implantation embryos. We show that CARS imaging can quantify the size, number and spatial distribution of lipid droplets in living mouse oocytes and embryos up to the blastocyst stage. Notably, it can be used in a way that does not compromise oocyte maturation or embryo development. We have also correlated CARS with two-photon fluorescence microscopy simultaneously acquired using fluorescent lipid probes on fixed samples, and found only a partial degree of correlation, depending on the lipid probe, clearly exemplifying the limitation of lipid labelling. In addition, we show that differences in the chemical composition of lipid droplets in living oocytes matured in media supplemented with different saturated and unsaturated fatty acids can be detected using CARS hyperspectral imaging. These results demonstrate that CARS microscopy provides a novel non-invasive method of quantifying lipid content, type and spatial distribution with sub-micron resolution in living mammalian oocytes and embryos.


Subject(s)
Embryo, Mammalian/cytology , Imaging, Three-Dimensional , Lipids/chemistry , Microscopy/methods , Oocytes/cytology , Spectrum Analysis, Raman , Animals , Cell Survival , Cluster Analysis , Embryo, Mammalian/metabolism , Embryonic Development , Female , Lipid Droplets/metabolism , Mice , Microscopy, Fluorescence , Oocytes/metabolism
2.
Mol Hum Reprod ; 21(10): 783-91, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26187950

ABSTRACT

Artificial oocyte activation to overcome failed fertilization after intracytoplasmic sperm injection (ICSI) in human oocytes typically employs Ca(2+) ionophores to produce a single cytosolic Ca(2+) increase. In contrast, recombinant phospholipase Czeta (PLCζ) causes Ca(2+) oscillations indistinguishable from those occurring during fertilization, but remains untested for its efficacy in a scenario of ICSI fertilization failure. Here, we compare PLCζ with other activation stimuli in a mouse model of failed oocyte activation after ICSI, in which heat-treated sperm are injected into mouse oocytes. We show that increasing periods of 56 °C exposure of sperm produces a progressive loss of Ca(2+) oscillations after ICSI. The decrease in Ca(2+) oscillations produces a reduction in oocyte activation and embryo development to the blastocyst stage. We treated such oocytes that failed to activate after ICSI either with Ca(2+) ionophore, or with Sr(2+) media which causes Ca(2+) oscillations, or we injected them with recombinant human PLCζ. All these treatments rescued oocyte activation, although Sr(2+) and PLCζ gave the highest rates of development to blastocyst. When recombinant PLCζ was given to oocytes previously injected with control sperm, they developed normally to the blastocyst stage at rates similar to that after control ICSI. The data suggest that recombinant human PLCζ protein is an efficient means of rescuing oocyte activation after ICSI failure and that it can be effectively used even if the sperm already contains endogenous Ca(2+) releasing activity.


Subject(s)
Calcium Signaling/drug effects , Infertility, Male/physiopathology , Oocytes/drug effects , Phosphoinositide Phospholipase C/pharmacology , Sperm Injections, Intracytoplasmic , Animals , Blastocyst , Disease Models, Animal , Embryonic Development/drug effects , Female , Fertilization/drug effects , Hot Temperature , Humans , Ionomycin/pharmacology , Ionophores/pharmacology , Male , Mice , Mice, Inbred Strains , Oocytes/physiology , Recombinant Fusion Proteins/pharmacology , Sperm Injections, Intracytoplasmic/methods , Strontium/pharmacology
3.
Mol Hum Reprod ; 21(9): 702-10, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26116451

ABSTRACT

Mammalian oocyte activation is mediated by cytosolic calcium (Ca(2+)) oscillations initiated upon delivery of a putative 'sperm factor' by the fertilizing sperm. Previous studies suggest the identity of this sperm factor as the testis-specific phospholipase C-zeta (PLCζ). Recently, a post-acrosomal sheath WW domain-binding protein (PAWP) has been proposed as an alternative sperm factor candidate, following a report that human PAWP protein and cRNA elicited Ca(2+) oscillations in mouse and human oocytes. Those Ca(2+) oscillations were inhibited by a PAWP-derived peptide corresponding to a functional PPGY binding motif. Herein, using a series of human PAWP expression constructs, we demonstrate that both human PAWP protein and cRNA are, in our experiments, unable to elicit Ca(2+) release following microinjection into mouse oocytes. Parallel experiments performed with human PLCζ elicited the characteristic Ca(2+) oscillations present at mammalian fertilization, which produced oocyte activation and embryo development. Furthermore, sperm-induced Ca(2+) oscillations were not inhibited by the PAWP-derived PPGY peptide following in vitro fertilization or intracytoplasmic sperm injection. Thus, the functional disparity with PLCζ leads us to conclude that human PAWP is neither sufficient nor necessary for the Ca(2+) oscillations that initiate mammalian oocyte activation at fertilization.


Subject(s)
Calcium Signaling , Carrier Proteins/metabolism , Oocytes/enzymology , Phosphoinositide Phospholipase C/metabolism , Seminal Plasma Proteins/metabolism , Animals , Calcium Signaling/drug effects , Carrier Proteins/genetics , Cells, Cultured , Female , Fertilization in Vitro , Gene Transfer Techniques , Humans , In Vitro Oocyte Maturation Techniques , Male , Mice , Microinjections , Oocytes/drug effects , Peptide Fragments/pharmacology , Phosphoinositide Phospholipase C/genetics , Seminal Plasma Proteins/genetics , Sperm Injections, Intracytoplasmic , Sperm-Ovum Interactions , Spermatozoa/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL